RxDoctor Payments Data

Lydia Moreno, APRN

Family · Jonesville, FLNPI 1497482426

Payments from drug & device makers

$1,627in general payments, 2019–2025

Across 90 payments — averaging $18.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$632
  • Exact Sciences$161
  • AstraZeneca$153
  • Boehringer Ingelheim$151
  • Novo Nordisk$134
  • AbbVie$132
  • plus $264 from 5 others

What the payments were for

  • Food & beverage$1,627100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,627 in reported general payments places this provider in the 75th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$1,165
Medicare patients
32
Services billed
61

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide28$43,614
JardianceEmpagliflozin27$32,561
FarxigaDapagliflozin Propanediol27$28,238
Trelegy ElliptaFluticasone/Umeclidin/Vilanter29$27,776
TrulicityDulaglutide17$17,164
EliquisApixaban14$9,992
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$9,502
Spiriva HandihalerTiotropium Bromide13$6,709
SymbicortBudesonide/Formoterol Fumarate22$6,210
Albuterol Sulfate HfaAlbuterol Sulfate101$2,876
ShingrixVaricella-Zoster Ge/As01b/Pf16$2,501
Fluticasone-SalmeterolFluticasone Propion/Salmeterol14$2,186
Gabapentin87$1,976
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$1,952
Ventolin HfaAlbuterol Sulfate23$1,926

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$153$43,95060 claims
Novo NordiskOzempic$134$43,61428 claims
Boehringer IngelheimJardiance$151$32,56127 claims
GSKTrelegy Ellipta, Shingrix$79$30,27745 claims
Lilly USA, LLCTrulicity$632$17,16417 claims
PfizerEliquis$88$9,99214 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 14,618 family providers in Florida.

Other family in Jonesville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →